Sam Lee - Jul 25, 2022 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Role
President and Co-Interim CEO
Signature
/s/ Sam Lee
Stock symbol
COCP
Transactions as of
Jul 25, 2022
Transactions value $
$0
Form type
4
Date filed
8/3/2022, 04:02 PM
Previous filing
Jul 20, 2021
Next filing
Jul 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COCP Stock Options (Right to Buy) Award $0 +300K $0.00 300K Jul 25, 2022 Common Stock 300K $0.42 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code (the "Code").
F2 The stock options vest and become exercisable as follows, subject in each case to the limitations on exercisability of incentive stock options under Section 422 of the Code: one-half will vest on July 25, 2023 and the remaining half will vest in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to continued employment on each applicable vesting date.